Acta Med. 2009, 52: 107-116

https://doi.org/10.14712/18059694.2016.114

A Study of Intima Media Thickness and Their Cardiovascular Risk Factors in Patients with Psoriatic Arthritis

Sadhanah Aqashiah Mazlana, Mohd Shahrir bin Mohamed Saidb, Heselynn Husseinc, Khadijah binti Shamsuddinb, Shamsul Azhar Shahb, Hamidon Basrid

aHospital Ampang, Medical Department, Kuala Lumpur, Malaysia
bUKM Medical Center, Medical Department, Kuala Lumpur, Malaysia
cHospital Putrajaya Medical Department, Putrajaya, Malaysia
dUniversity Putra Malaysia, Medical Department, Serdang, Malaysia

Received April 13, 2009
Accepted August 28, 2009

References

1. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ. Rheumatoid arthritis and macrovascular disease. Rheumatology(Oxford) 2003; 42:292–7. <https://doi.org/10.1093/rheumatology/keg083>
2. Bartoli F, Blagojevic J, Bacci M, et al. Flow mediated vasodilatation and carotid intima-media thickness in systemic sclerosis. Ann N Y Acad Sci 2007; 1108: 283–90. <https://doi.org/10.1196/annals.1422.030>
3. Beyne-Rauzy O, P Leger, A Godel, et al. Intima-media thickness evaluation in 45 systemic scleroses compared to healthy subjects matched for sex and gender. The johns Hopkins arthritis center. Abstract 1678. 1998–2007.
4. Boehncke S, Thaci D, Beschmann H, et al. Psoriasis shows signs of insulin resistance. Br J Dermatol 2007; 157:1249–51. <https://doi.org/10.1111/j.1365-2133.2007.08190.x>
5. Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005; 23(suppl 39):S1–S14.
6. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999 Apr; 30(4):841–50. <https://doi.org/10.1161/01.STR.30.4.841>
7. Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al. Subclinical artherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 2008 May; 35(5):877–82. Epub 2008 Mar 15.
8. El Miedany Y. Recent developments in management of psoriatic arthritis. Curr Rheumatol Rep 2005; 1:9–39. <https://doi.org/10.2174/1573397052954154>
9. Gerfand E. Heart disease and psoriasis link grows stronger: New studies indicate elevated risk for myocardial infarction. Skin and Allergy News 2006; 37(6):1.
10. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007 Jul; 157(1):68–73. <https://doi.org/10.1111/j.1365-2133.2007.07986.x>
11. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez- Gay MA. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007 Aug 15; 57(6):1074–80. <https://doi.org/10.1002/art.22884>
12. Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, et al. Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 2006 Apr; 35(5):333–9. <https://doi.org/10.1016/j.semarthrit.2005.12.002>
13. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid Arthritis. Arthritis Rheum 1992; 35(5):498–502. <https://doi.org/10.1002/art.1780350502>
14. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima media thickness in predicting clinical coronary events. Ann Intern Med 1998 Feb 15; 128(4):262–9. <https://doi.org/10.7326/0003-4819-128-4-199802150-00002>
15. Kavanaugh A. Cassell S. The assessment of disease activity and outcomes in psoriatic arthritis. Clin Exp Rheumatol 2005; 23(39):142–7.
16. Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of athrosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007 Feb; 36(4):203–9. <https://doi.org/10.1016/j.semarthrit.2006.09.001>
17. Leger P, Beyne-Rauzy O, Arista S, et al. Macrovascular disease assessment in systemic sclerosis: results of a prospective case-control study. Abstract 1683.1998–2007.
18. Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007 Feb; 156(2):271–6. <https://doi.org/10.1111/j.1365-2133.2006.07562.x>
19. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematousus. Arthritis Rheum 1999 Jan; 42(1):51–60. <https://doi.org/10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D>
20. Mease P, Goffe BS. Diagnosis and treatment of psoriatic arthritis. J Am Acad Dermatol 2005; 52:1–19. <https://doi.org/10.1016/j.jaad.2004.06.013>
21. Naldi L. Chatenoud L, Linder D, et al. Cigarette smoking, body mass index and stressful life events as risk factors for psoriasis: results from Italian case control study. J Invest Dermatol 2005 Jul; 125(1):61–7. <https://doi.org/10.1111/j.0022-202X.2005.23681.x>
22. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999 Jan 7; 340(1):14–22. <https://doi.org/10.1056/NEJM199901073400103>
23. Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease scores that include twenty-eight joint counts. Development and validation in prospective longitudinal study of patients with Rheumatoid Arthritis. Arthritis Rheum 1995; 38:44–8. <https://doi.org/10.1002/art.1780380107>
24. Prodanovich S, Ma F, Taylor JR, Pevon C, Fasihi T, Kirsner RS. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol Feb 2005; 52(2):262–7. <https://doi.org/10.1016/j.jaad.2004.06.017>
25. Saricaoglu H, Güllülü S, Bülbül Baskan E, Cordan J, Tunali S. Echocardiographic findings in subjects with psoriatic arthropathy. J Eur Acad Dermatol Venereol Jul 2003; 17(4):414–7. <https://doi.org/10.1046/j.1468-3083.2003.00748.x>
26. Sattar N, McCarey DW, Capell H, McInnes IB. Explaning how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108:2957–63. <https://doi.org/10.1161/01.CIR.0000099844.31524.05>
27. Sidhu PS, Desai SR. A simple and reproducible method for assessing intimalmedial thickness of the common carotid artery. Br J Radiol 1997 Jan; 70: 85–9. <https://doi.org/10.1259/bjr.70.829.9059301>
28. Skogh T, Gustafsson D, Kjellberg M, Husberg M. Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate. Ann Rheum Dis 2003; 62:681–2. <https://doi.org/10.1136/ard.62.7.681> <PubMed>
29. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298:321–8. <https://doi.org/10.1007/s00403-006-0703-z>
30. Tam LS, Shang Q, Li EK, et al. Subclinical carotid artherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 2008 Sep 15; 59(9):1322–31. <https://doi.org/10.1002/art.24014>
31. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis. Development of new criteria from a large international study. Arthritis Rheum 2006 Aug; 54(8):2665–73. <https://doi.org/10.1002/art.21972>
32. Tewari S, Garg N, Kapoor A, et al. Association of common carotid intima-media thickness and lipoprotein (a) with coronary artery disease. Indian Heart J 2004; 56:642–5.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive